Patent law

Oriental Yuhong Obtains an Invention Patent in Singapore after One in the US

Retrieved on: 
Monday, July 13, 2020
Intangible assets, United States patent law, Patent, Patent law

BEIJING, July 12, 2020 /PRNewswire/ -- Oriental Yuhong's product - HDPE polymer waterproof coiled material- has recently obtained a patent (patent NO.

Key Points: 
  • BEIJING, July 12, 2020 /PRNewswire/ -- Oriental Yuhong's product - HDPE polymer waterproof coiled material- has recently obtained a patent (patent NO.
  • 11201705060T) by the IP Australia and a patent by the United States Patent and Trademark Office (patent NO.
  • In 2019, Oriental Yuhong broke the European and American monopoly and participated in the construction of a subway in Singapore.
  • Due to the regional requirements and protection of the product patent, Oriental Yuhong applied for a patent on its HDPE product in Singapore in advance.

BAB, Inc. Reports Results for 2nd Quarter FY 2020

Retrieved on: 
Friday, July 10, 2020
Articles, Global health, Economy, Expense, Intellectual property law, Patent law, Royalty payment, Babb, Revenue, Pandemic, Net income, Franchising

DEERFIELD, Ill., July 10, 2020 (GLOBE NEWSWIRE) -- BAB, Inc. (OTCQB: BABB)announced its financial results for the second quarter ended May 31, 2020.

Key Points: 
  • DEERFIELD, Ill., July 10, 2020 (GLOBE NEWSWIRE) -- BAB, Inc. (OTCQB: BABB)announced its financial results for the second quarter ended May 31, 2020.
  • Royalty revenue, license fees and other income and marketing fund revenue all decreased for the second quarter 2020 because of the effect of the Coronavirus pandemic on franchisee sales.
  • The Coronavirus pandemic which occurred in the second quarter 2020 has affected the revenues and net income, creating lower revenues and a year to date loss.
  • Total operating expenses for the quarter ended May 31, 2020, were $423,000, versus $641,000 in 2019.

Global Antibody Partnering Deals Collection 2014-2020 - Access to 1,300+ Online Deal Records; Headline, Upfront, Milestone and Royalty Data

Retrieved on: 
Friday, July 10, 2020
Magazines, Expense, Intellectual property law, Patent law, Royalty payment, Project DEAL, Antibody, The Deal, Contract, Branches of biology, Periodicals

Chapter 2 provides an overview of the trends in Antibody dealmaking since 2014, including details of average headline, upfront, milestone and royalty terms.

Key Points: 
  • Chapter 2 provides an overview of the trends in Antibody dealmaking since 2014, including details of average headline, upfront, milestone and royalty terms.
  • Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
  • Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
  • Chapter 7 provides a comprehensive and detailed review of Antibody partnering deals signed and announced since Jan to 2014.

Patent Bots Releases New Legal Rankings For Tracking Patent Quality

Retrieved on: 
Wednesday, July 8, 2020
Intellectual property law, Patent law, Monopoly, Patent, United States patent law, Outline of patents

Patent Bots downloaded 310,842 publicly available patents from the United States Patent and Trademark Office and then used the company's AI-powered, automated patent proofreading toolto count the number of errors in each issued patent.

Key Points: 
  • Patent Bots downloaded 310,842 publicly available patents from the United States Patent and Trademark Office and then used the company's AI-powered, automated patent proofreading toolto count the number of errors in each issued patent.
  • The Patent Law Firm Quality Scores provide public recognition for patent firms doing exceptionally high quality work in avoiding legal errors in issued patents.
  • Patent law firms outside of the top 50 can login to the Patent Bots website to see their own quality scores and where they stand with respect to other patent law firms.
  • Moreover, Patent Bots plans on releasing more data-driven insights about other aspects of patent quality to improve the patent industry.

Heritage Global Patents & Trademarks to Conduct Global Sealed-Bid Auction of Cancer Therapeutic Patent Portfolio

Retrieved on: 
Wednesday, July 8, 2020
Intellectual property law, Intangible assets, Patent law, Articles, Monopoly, Intellectual property brokering, Software distribution, Patent monetization, Patent, Intellectual property, Monetization, Outline of patents

Heritage Global Inc. (OTCQB: HGBL, CSE: HGP) is a diversified financial services company providing acquisition, disposition, valuation and lending services for surplus and distressed assets.

Key Points: 
  • Heritage Global Inc. (OTCQB: HGBL, CSE: HGP) is a diversified financial services company providing acquisition, disposition, valuation and lending services for surplus and distressed assets.
  • Heritage Global Patents & Trademarks is the Intellectual Property Division of Heritage Global Inc. and provides a patent monetization services via Patent Auctions and Patent Brokerage on its online monetization platform The Patent Exchange.

Shockwave Announces Decisions From the U.S. Patent and Trademark Office on Inter Partes Review Proceeding

Retrieved on: 
Wednesday, July 8, 2020
Intellectual property law, United States patent law, Patent law, Patent Trial and Appeal Board, PTAB, United States Patent and Trademark Office, Patent, Versata Development Group, Inc. v. SAP America, Inc., Inter partes review

In December 2018, CSI filed petitions for IPR with the Patent Trial and Appeal Board (PTAB) of the U.S. Patent Office (USPTO) to challenge the validity of three of Shockwaves issued patents.

Key Points: 
  • In December 2018, CSI filed petitions for IPR with the Patent Trial and Appeal Board (PTAB) of the U.S. Patent Office (USPTO) to challenge the validity of three of Shockwaves issued patents.
  • The PTAB ruled today that a key claim in U.S. Patent No 8,956,371 (the 371 patent) is valid.
  • This claim is generally directed to a device that creates shockwaves inside of a balloon catheter that is delivered over a guidewire.
  • Further, the PTAB ruled today that some claims of the U.S. Patent No 8,956,371 are invalid and that all claims of U.S. Patent No 8,728,091 (the 091 patent) are invalid.

Octiive Moves to Accelerate Artist’s Creativity and Careers

Retrieved on: 
Wednesday, July 8, 2020
Information science, Expense, Intellectual property law, Patent law, Royalty payment, Corum, Personalization, Pricing

At Octiive, were all musicians, and weve optimized everything to create the platform that serves artists best, said Dakota Corum, Octiive's Director of Operations.

Key Points: 
  • At Octiive, were all musicians, and weve optimized everything to create the platform that serves artists best, said Dakota Corum, Octiive's Director of Operations.
  • With our reconfigured plan offerings we are able to give more to artists who are passionate about what they are doing.
  • Since its inception, Octiive has earned its members millions of dollars in royalties, offering artists a hybrid pricing model flexible to their unique needs and interests.
  • Blending both a streamlined and personalized approach to helping artists build their careers, Octiive brings the best value in the market today.

Sabina Gold & Silver Reports Goose Camp Open for Expanded Drilling Campaign at the Back River Gold Project

Retrieved on: 
Wednesday, July 8, 2020
Physical sciences, Chemistry, Atoms, Expense, Intellectual property law, Patent law, Royalty payment, Hackett, Silver, Physical sciences, Chemistry, Atoms, Expense, Intellectual property law, Patent law, Royalty payment, Hackett, Silver

This years campaign will also enable us to prepare for the significant drilling required to bring these targets into a resource estimate.

Key Points: 
  • This years campaign will also enable us to prepare for the significant drilling required to bring these targets into a resource estimate.
  • In addition to Back River, Sabina also owns a significant silver royalty on Glencores Hackett River Project.
  • The silver royalty on Hackett Rivers silver production is comprised of 22.5% of the first 190 million ounces produced and 12.5% of all silver produced thereafter.
  • For further information please contact:
    This news release has been authorized by the undersigned on behalf of Sabina Gold & Silver Corp.

PrairieSky Royalty Announces Conference Call for Q2 2020 Results

Retrieved on: 
Tuesday, July 7, 2020
Expense, Intellectual property law, Patent law, Royalty payment

CALGARY, Alberta, July 07, 2020 (GLOBE NEWSWIRE) -- PrairieSky will release its Q2 2020 results on Monday, July20, 2020 after markets close.

Key Points: 
  • CALGARY, Alberta, July 07, 2020 (GLOBE NEWSWIRE) -- PrairieSky will release its Q2 2020 results on Monday, July20, 2020 after markets close.
  • The news release detailing PrairieSkys Q2 2020 results will provide operating and financial information.
  • A conference call to discuss the results will be held for the investment community on Tuesday, July21, 2020 beginning at 6:30 am MT (8:30 am ET).
  • To participate in the conference call, approximately 10 minutes prior to the conference call, please dial:
    PrairieSky is a royalty-focused company, generating royalty revenues as petroleum and natural gas are produced from its properties.

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China

Retrieved on: 
Tuesday, July 7, 2020
Expense, Intellectual property law, Patent law, Royalty payment, Zai, Companies

Under the terms of the agreement, Zai Lab will obtain exclusive rights to develop and commercialize repotrectinib in Greater China and Turning Point Therapeutics will receive a $25 million upfront payment, with potential to receive up to an additional $151 million in development, regulatory and sales-based milestone payments.

Key Points: 
  • Under the terms of the agreement, Zai Lab will obtain exclusive rights to develop and commercialize repotrectinib in Greater China and Turning Point Therapeutics will receive a $25 million upfront payment, with potential to receive up to an additional $151 million in development, regulatory and sales-based milestone payments.
  • Turning Point will also be eligible to receive mid-to-high teen royalties based on annual net sales of repotrectinib in Greater China.
  • Our collaboration with Zai Lab is a strategic step to potentially accelerate the development of repotrectinib in Greater China.
  • We are very pleased to enter into this agreement with Turning Point Therapeutics.